| Literature DB >> 35020740 |
Muhammad Umair Sial1,2, Khalid Mehmood1, Shafqat Saeed1, Mureed Husain3, Khawaja Ghulam Rasool3, Abdulrahman Saad Aldawood3.
Abstract
Green peach aphid [Myzus persicae (Sulzer) (Hemiptera: Aphididae)] is a significant pest with a known history of insecticide resistance. Neonicotinoids could manage this pest; however, their frequent use led to the evolution of resistance in field populations of M. persicae. Toxicity data for neonicotinoid insecticides synergized with pipernyl butoxide (PBO) in a field population (FP) were collected and compared to a laboratory susceptible clone (SC) of aphids. The enhanced expression of metabolic resistance-related cytochrome P450 gene CYP6CY3 and an arginine-threonine substitution were detected in FP, causing a single point mutation (R81T) at β1 subunit of nicotinic acetylcholine receptor (nAChR) within D loop. High level of resistance to imidacloprid was developed in FP with 101-fold resistance ratio and moderate resistance level (10.9-fold) to acetamiprid. The results of PBO synergized bioassay suggested that cytochrome P450 enzymes were involved in the resistance to neonicotinoids. The mRNA transcriptional level of CYP6CY3 gene was significantly higher (3.74 fold) in FP compared to SC. The R81T mutation associated with neonicotinoid resistance had 26% resistant allele frequency in FP. Both P450 enzymes and R81T mutation of nAChR were found in field-evolved neonicotinoid resistance. It is concluded that field-evolved resistance in green peach aphid could be managed by using appropriate synergists such as PBO.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35020740 PMCID: PMC8766173 DOI: 10.1371/journal.pone.0261090
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Primers used in expression evaluation of cytochrome P450 CYP6CY3 and esterase E4 genes and sequence analysis of nAChR in Myzus persicae.
| Genes | Primer Sequence (5´-3´) | Amplicon size (bp) | Reference | |
|---|---|---|---|---|
| Forward primer | Reverse primer | |||
| R81T |
|
| 619 | [ |
| CYP6CY3 |
|
| 128 | [ |
| E4 |
|
| 160 | [ |
|
|
| 120 | [ | |
Dose-response toxicity bioassay of imidacloprid and acetamiprid to susceptible clone (SC) and field population (FP).
| Population | Insecticide | LC50 (mg/L) | 95%CL | Slope (±SE) |
| χ2 |
| RF |
|---|---|---|---|---|---|---|---|---|
| (mg/L) | ||||||||
| SC | Imidacloprid | 0.002 | 0.001–0.003 | 0.89 (±0.15) | 5 | 2.05 | 0.84 | 1.00 |
| Acetamiprid | 0.024 | 0.017–0.034 | 1.41 (±0.18) | 5 | 10.5 | 0.06 | 1.00 | |
| FP | Imidacloprid | 0.203 | 0.084–0.845 | 1.04 (±0.16) | 5 | 12.2 | 0.03 | 101 |
| Acetamiprid | 0.261 | 0.177–0.389 | 1.13 (±0.17) | 5 | 4.22 | 0.52 | 10.9 |
Confidence limits;
standard error;
degrees of freedom;
Chi-square value;
resistance factor
Synergistic effect of PBO on the toxicity of imidacloprid and acetamiprid to susceptible clone (SC) and field population (FP) of M. persicae.
| Strain | Insecticide | LC50 (mg/L) | 95%CL | Slope (±SE) |
| χ2 |
| RF | SF |
|---|---|---|---|---|---|---|---|---|---|
| (mg/L) | |||||||||
| SC | Imidacloprid+PBO | 0.002 | 0.002–0.004 | 0.974(±0.16) | 5 | 2.73 | 0.74 | 1.00 | 1.00 |
| Acetamiprid+PBO | 0.025 | 0.016–0.041 | 0.98 (±0.16) | 5 | 2.55 | 0.77 | 1.00 | 0.96 | |
| FP | Imidacloprid+PBO | 0.033 | 0.013–0.058 | 0.81 (±0.16) | 5 | 2.50 | 0.78 | 16.5 | 6.15 |
| Acetamiprid+PBO | 0.087 | 0.006–0.451 | 0.98 (±0.16) | 5 | 20.1 | 0.01 | 3.48 | 3.00 |
Confidence limits;
standard error;
degrees of freedom;
Chi-square value;
resistance factor;
synergism factor
Fig 1Relative mRNA transcriptional levels of (A) cytochrome P450 CYP6CY3 and (B) E4 in susceptible clone (SC) and field population (FP) of Myzus persicae. Data are presented as means ± SE from three independent experiments for each strain. The symbol (*) is used to denote significant difference (p<0.05).
Genotype and allelic frequencies of the R81T mutation in susceptible clone (SC) and field population (FP) of Myzus persicae.
| Mutation | Population |
| Genotype | |||
|---|---|---|---|---|---|---|
| RR | SR | SS | RAF (%) | |||
| R81T | SC | 50 | 0 | 0 | 50 | 0 |
| FP | 6 | 14 | 30 | 26.0 | ||
| V101M (I) | SC | 0 | 0 | 50 | 0 | |
| FP | 2 (14) | 10 (4) | 20 | 14.0 (32.0) | ||
number of individuals;
resistant homozygote;
resistant heterozygote;
susceptible homozygote;
resistance allele frequency (RAF) = 100×(2×RR+SR)/2n.
Fig 2Schematic of the Myzus persicae nicotinic acetylcholine receptor, the primary target of the neonicotinoids, showing a single mutation R81T position along with additionally found Val101Met, V101Ile mutations on β-subunit at loop D.
Coding domain of loop D nAChR of R81 (45 bp) and V101 (110 bp) mutation is presented as AGA‒>ACA and GTG‒>ATG / GTG‒>ATA, respectively. Acetylcholine binding loop E and F are also presented on the protein-coding domain. Reproduced from [8, 24].